Hodgkin Disease Refractory
📧 Sign up to get email alerts when something new happens for Hodgkin Disease Refractory.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-04-05Clinical Trial Update: Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT) [Phase 2]
Phase 2 trial update for autologous CD30.CAR-T cells in relapsed/refractory Hodgkin lymphoma (CHARIOT) is ongoing (Phase 2, active not recru…